vs
FLUSHING FINANCIAL CORP（FFIC）与RECURSION PHARMACEUTICALS, INC.（RXRX）财务数据对比。点击上方公司名可切换其他公司
FLUSHING FINANCIAL CORP的季度营收约是RECURSION PHARMACEUTICALS, INC.的1.7倍（$58.8M vs $35.5M），FLUSHING FINANCIAL CORP净利率更高（6.8% vs -304.2%，领先311.1%），FLUSHING FINANCIAL CORP同比增速更快（2597.7% vs 681.7%），FLUSHING FINANCIAL CORP自由现金流更多（$55.8M vs $-47.3M），过去两年RECURSION PHARMACEUTICALS, INC.的营收复合增速更高（60.5% vs 13.7%）
弗拉格斯塔夫银行（Flagstar Bank, N.A.）是美国区域性金融服务控股集团，总部位于纽约希克斯维尔。2023年该行共运营395家分支机构，并于2024年2月21日完成全部分支机构的品牌统一，全部更名为Flagstar品牌。
Recursion Pharmaceuticals是一家临床阶段生物技术企业，依托人工智能技术和高通量生物实验体系，开发针对罕见病、肿瘤、炎症性疾病等领域未满足医疗需求的创新疗法，核心市场覆盖北美，与全球多家生物制药企业合作推进在研管线落地。
FFIC vs RXRX — 直观对比
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $58.8M | $35.5M |
| 净利润 | $4.0M | $-108.1M |
| 毛利率 | — | 59.8% |
| 营业利润率 | 13.3% | -304.8% |
| 净利率 | 6.8% | -304.2% |
| 营收同比 | 2597.7% | 681.7% |
| 净利润同比 | 108.2% | 39.6% |
| 每股收益（稀释后） | $0.12 | $-0.17 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
| Q4 25 | $58.8M | $35.5M | ||
| Q3 25 | $58.6M | $5.2M | ||
| Q2 25 | $63.5M | $19.2M | ||
| Q1 25 | $58.1M | $14.7M | ||
| Q4 24 | $2.2M | $4.5M | ||
| Q3 24 | $51.9M | $26.1M | ||
| Q2 24 | $47.0M | $14.4M | ||
| Q1 24 | $45.5M | $13.8M |
| Q4 25 | $4.0M | $-108.1M | ||
| Q3 25 | $10.4M | $-162.3M | ||
| Q2 25 | $14.2M | $-171.9M | ||
| Q1 25 | $-9.8M | $-202.5M | ||
| Q4 24 | $-49.2M | $-178.9M | ||
| Q3 24 | $8.9M | $-95.8M | ||
| Q2 24 | $5.3M | $-97.5M | ||
| Q1 24 | $3.7M | $-91.4M |
| Q4 25 | — | 59.8% | ||
| Q3 25 | — | -183.8% | ||
| Q2 25 | — | -4.9% | ||
| Q1 25 | — | -48.0% | ||
| Q4 24 | — | -181.4% | ||
| Q3 24 | — | 53.7% | ||
| Q2 24 | — | 36.2% | ||
| Q1 24 | — | 19.1% |
| Q4 25 | 13.3% | -304.8% | ||
| Q3 25 | 23.4% | -3327.6% | ||
| Q2 25 | 29.8% | -916.8% | ||
| Q1 25 | -10.2% | -1297.9% | ||
| Q4 24 | -3296.2% | -4042.4% | ||
| Q3 24 | 22.1% | -377.1% | ||
| Q2 24 | 15.2% | -697.4% | ||
| Q1 24 | 11.0% | -698.4% |
| Q4 25 | 6.8% | -304.2% | ||
| Q3 25 | 17.8% | -3135.3% | ||
| Q2 25 | 22.4% | -894.2% | ||
| Q1 25 | -16.9% | -1373.3% | ||
| Q4 24 | -2258.9% | -3935.5% | ||
| Q3 24 | 17.2% | -367.5% | ||
| Q2 24 | 11.3% | -676.6% | ||
| Q1 24 | 8.1% | -662.4% |
| Q4 25 | $0.12 | $-0.17 | ||
| Q3 25 | $0.30 | $-0.36 | ||
| Q2 25 | $0.41 | $-0.41 | ||
| Q1 25 | $-0.29 | $-0.50 | ||
| Q4 24 | $-1.67 | $-0.56 | ||
| Q3 24 | $0.30 | $-0.34 | ||
| Q2 24 | $0.18 | $-0.40 | ||
| Q1 24 | $0.12 | $-0.39 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | — | $743.3M |
| 总债务越低越好 | — | $9.6M |
| 股东权益账面价值 | $708.0M | $1.1B |
| 总资产 | $8.7B | $1.5B |
| 负债/权益比越低杠杆越低 | — | 0.01× |
8季度趋势，按日历期对齐
| Q4 25 | — | $743.3M | ||
| Q3 25 | — | $659.8M | ||
| Q2 25 | — | $525.1M | ||
| Q1 25 | — | $500.5M | ||
| Q4 24 | — | $594.4M | ||
| Q3 24 | — | $427.6M | ||
| Q2 24 | — | $474.3M | ||
| Q1 24 | — | $296.3M |
| Q4 25 | — | $9.6M | ||
| Q3 25 | — | $11.9M | ||
| Q2 25 | — | $14.2M | ||
| Q1 25 | — | $16.4M | ||
| Q4 24 | — | $19.0M | ||
| Q3 24 | — | $20.5M | ||
| Q2 24 | — | $22.9M | ||
| Q1 24 | — | — |
| Q4 25 | $708.0M | $1.1B | ||
| Q3 25 | $711.2M | $1.0B | ||
| Q2 25 | $706.4M | $919.1M | ||
| Q1 25 | $702.9M | $933.9M | ||
| Q4 24 | $724.5M | $1.0B | ||
| Q3 24 | $666.9M | $524.6M | ||
| Q2 24 | $665.3M | $584.4M | ||
| Q1 24 | $669.8M | $401.2M |
| Q4 25 | $8.7B | $1.5B | ||
| Q3 25 | $8.9B | $1.4B | ||
| Q2 25 | $8.8B | $1.3B | ||
| Q1 25 | $9.0B | $1.3B | ||
| Q4 24 | $9.0B | $1.4B | ||
| Q3 24 | $9.3B | $726.5M | ||
| Q2 24 | $9.1B | $775.9M | ||
| Q1 24 | $8.8B | $557.8M |
| Q4 25 | — | 0.01× | ||
| Q3 25 | — | 0.01× | ||
| Q2 25 | — | 0.02× | ||
| Q1 25 | — | 0.02× | ||
| Q4 24 | — | 0.02× | ||
| Q3 24 | — | 0.04× | ||
| Q2 24 | — | 0.04× | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $61.0M | $-46.1M |
| 自由现金流经营现金流 - 资本支出 | $55.8M | $-47.3M |
| 自由现金流率自由现金流/营收 | 94.9% | -133.1% |
| 资本支出强度资本支出/营收 | 8.9% | 3.5% |
| 现金转化率经营现金流/净利润 | 15.16× | — |
| 过去12个月自由现金流最近4个季度 | $104.7M | $-378.3M |
8季度趋势，按日历期对齐
| Q4 25 | $61.0M | $-46.1M | ||
| Q3 25 | $19.6M | $-117.4M | ||
| Q2 25 | $25.8M | $-76.4M | ||
| Q1 25 | $6.9M | $-132.0M | ||
| Q4 24 | $12.4M | $-115.4M | ||
| Q3 24 | $5.4M | $-59.2M | ||
| Q2 24 | $9.6M | $-82.2M | ||
| Q1 24 | $-6.2M | $-102.3M |
| Q4 25 | $55.8M | $-47.3M | ||
| Q3 25 | $19.3M | $-117.6M | ||
| Q2 25 | $24.4M | $-79.6M | ||
| Q1 25 | $5.2M | $-133.8M | ||
| Q4 24 | $10.1M | $-116.7M | ||
| Q3 24 | $4.8M | $-63.8M | ||
| Q2 24 | $8.8M | $-83.4M | ||
| Q1 24 | $-6.5M | $-109.0M |
| Q4 25 | 94.9% | -133.1% | ||
| Q3 25 | 33.0% | -2272.5% | ||
| Q2 25 | 38.5% | -413.9% | ||
| Q1 25 | 8.9% | -907.4% | ||
| Q4 24 | 463.4% | -2567.7% | ||
| Q3 24 | 9.3% | -244.6% | ||
| Q2 24 | 18.7% | -578.5% | ||
| Q1 24 | -14.3% | -789.9% |
| Q4 25 | 8.9% | 3.5% | ||
| Q3 25 | 0.4% | 4.7% | ||
| Q2 25 | 2.1% | 16.4% | ||
| Q1 25 | 2.9% | 12.4% | ||
| Q4 24 | 106.0% | 28.6% | ||
| Q3 24 | 1.1% | 17.5% | ||
| Q2 24 | 1.7% | 8.2% | ||
| Q1 24 | 0.6% | 48.2% |
| Q4 25 | 15.16× | — | ||
| Q3 25 | 1.87× | — | ||
| Q2 25 | 1.81× | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 0.61× | — | ||
| Q2 24 | 1.80× | — | ||
| Q1 24 | -1.69× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
